Dementia, Mild: Clinical Trials

1 trial for Dementia, Mild, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Dementia, Mild: new trials by email Literature Review of Dementia, Mild trials Research Report on Dementia, Mild

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
ALZ-101, Placebo - Alzheimer Disease, Dementia Alzheimers
Phase 1CompletedAlzinova AB332021-09-302025-01-31

Narrower conditions

Alzheimer Disease (1)  ·  Dementia (1)  ·  Lymphoma, Follicular (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Mental Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)

Sponsors

Alzinova AB (1)

Countries

Finland (1)

Top investigators

Juha Rinne, MD (1)

Results publications

PMID 42157213

NIH funding

2019 (1)